Literature DB >> 15386389

Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.

Axel Walch1, Katja Specht, Herbert Braselmann, Hubert Stein, Jörg Rüdiger Siewert, Ulrich Hopt, Heinz Höfler, Martin Werner.   

Abstract

The human growth factor receptor-bound protein 7 gene (GRB7), the founding member of a family of adaptor molecules has been shown to regulate cell migration and has been implicated in tumor progression. GRB7 is localized in close proximity to the ERBB2 gene within an amplicon previously identified in Barrett's adenocarcinoma (BCA). We evaluated gene amplification and mRNA expression of GRB7 and ERBB2 in Barrett's carcinoma and its associated precursor lesions to assess their possible role in Barrett's malignant transformation. Copy number and expression levels were analyzed by Q-PCR (GRB7, ERBB2) and QRT-PCR (GRB7, ERBB2) using TaqMan technology and fluorescence in situ hybridization (ERBB2) in a series of 24 laser-microdissected samples of Barrett's carcinomas and 32 samples of associated premalignant lesions. Parallel analysis of gene copy number changes and expression levels demonstrated that GRB7 and ERBB2 displayed concomitant elevated expression levels and increased copy numbers in 32% of Barrett's carcinomas. There was a correlation between GRB7 and ERBB2 in BCA at the DNA level (r(s) = 0.76, p < 0.001) and the mRNA level (r(s) = 0.89, p < 0.001). Moreover, coamplification (r(s) = 0.97, p < 0.001) and coexpression (r(s) = 0.81, p < 0.001) of GRB7 and ERBB2 are shown to be already present in a subset of BCA associated high-grade intraepithelial neoplasia (HGIN), possibly reflecting a role of a concerted expression of GRB7 and ERBB2. No alterations, neither gene amplification nor overexpression were detected in Barrett's carcinoma associated low grade intraepithelial neoplasia (LGIN), intestinal metaplasia (IM) and squamous epithelium, indicating that alterations of GRB7 and ERBB2 are late events in the carcinogenesis of Barrett's esophagus. These findings may be of particular interest because the transition from high grade intraepithelial neoplasia to invasive carcinoma is a crucial step in malignant transformation in Barrett's carcinogenesis and might underline the putative role of GRB7 and ERBB2 in cell migration and tumor invasion. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15386389     DOI: 10.1002/ijc.20411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.

Authors:  Sally Pias; Tabitha A Peterson; Dennis L Johnson; Barbara A Lyons
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

3.  Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.

Authors:  Nigus D Ambaye; Menachem J Gunzburg; Daouda A K Traore; Mark P Del Borgo; Patrick Perlmutter; Matthew C J Wilce; Jacqueline A Wilce
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-01-21       Impact factor: 1.056

Review 4.  [Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy].

Authors:  M Werner; S Lassmann
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Characterization of a novel tumorigenic esophageal adenocarcinoma cell line: OANC1.

Authors:  Nicholas J Clemons; Hongdo Do; Christina Fennell; Siddhartha Deb; Andrew Fellowes; Alexander Dobrovic; Wayne A Phillips
Journal:  Dig Dis Sci       Date:  2014-01       Impact factor: 3.199

Review 6.  Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.

Authors:  Kaushik Mukherjee; A Bapsi Chakravarthy; Laura W Goff; Wael El-Rifai
Journal:  Dig Dis Sci       Date:  2010-03-19       Impact factor: 3.199

7.  Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.

Authors:  Manman Zeng; Zhu Yang; Xiaoyu Hu; Yi Liu; Xiaotao Yang; Hailong Ran; Yanan Li; Xu Li; Qiubo Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis.

Authors:  Pei-Yu Chu; Ling-Ya Huang; Chun-Hua Hsu; Chun-Chi Liang; Jun-Lin Guan; Ting-Hsuan Hung; Tang-Long Shen
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

9.  Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.

Authors:  David W Chan; Winnie W Y Hui; Patty C H Cai; Michelle X Liu; Mingo M H Yung; Celia S L Mak; Thomas H Y Leung; Karen K L Chan; Hextan Y S Ngan
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.

Authors:  Sabina Berezowska; Alexander Novotny; Karina Bauer; Annette Feuchtinger; Julia Slotta-Huspenina; Karen Becker; Rupert Langer; Axel Walch
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.